NASDAQ · Drug Manufacturers - Specialty & Generic

FSD Pharma Inc. (HUGE) Stock

$0.09 -10.10% NASDAQ: HUGE Healthcare

FSD Pharma Inc. is a biopharmaceutical research and development company, operating through its various subsidiaries.

Valuation

MetricValue
Price$0.09
Market Cap$66671
P/E Ratio-0.19
P/B Ratio0.27
P/S Ratio0.00
EPS (TTM)$-0.47
52-Week High$109.19
52-Week Low$0.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-84.81%
ROA-106.24%
ROCE-154.10%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.03
Current Ratio2.44

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$0$0
Operating Profit$-31.0M$-31.0M$-34.0M$-27.0M$-20.0M
Net Profit$-40.0M$-33.0M$-35.0M$-23.0M$-19.0M
EPS$-5.68$-2.72$-1.01$-0.60$-0.47
Op Margin-15536.3%————

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$44.0M$42.0M$63.0M$38.0M$17.0M
Total Liabilities$7.0M$6.0M$9.0M$8.0M$5.0M
Cash$6.0M$18.0M$35.0M$17.0M$3.0M
Borrowings$2.0M$1.0M$1.0M$1.0M$0

Latest News

Tenet Healthcare (THC) Reports Earnings Tomorrow: What To Expect StockStory · Jul 23, 2026 Low-Cost Developed Markets or Emerging-Market Tech Exposure? VEA vs. IEMG Motley Fool · Jul 23, 2026 GE Vernova’s AI power trade has one weak link TheStreet · Jul 23, 2026 Flagstar Financial Earnings: What To Look For From FLG StockStory · Jul 23, 2026 Eni and KazMunayGas Reach Key Milestone at Kazakhstan Hybrid Power Plant Oilprice.com · Jul 23, 2026

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-14.0M$-19.0M$-21.0M$-28.0M$-11.0M
Investing Cash Flow$-1.0M$7.0M$0$12.0M$0
Financing Cash Flow$4.0M$0$0$-2.0M$-3.0M
Net Cash Flow$-10.0M$12.0M$18.0M$-18.0M$-14.0M
Free Cash Flow$-15.0M$-19.0M$-21.0M$-29.0M$-11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.15
FCF Yield-16537.66%
Quick Ratio2.44
Interest Coverage-65451.89
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACORAcorda Therapeutics, Inc. $0.66 -24.02% 0.00 $821028 0.00%
BFRI $1.17 -4.88% -0.90 $14.98M 0.00%
BHHKFCraftport Cannabis Corp. $0.00 — 0.00 $884 0.00%
CNNACann American Corp. $0.01 +8.33% 0.53 $4.80M 0.00%
CVGRFCity View Green Holdings Inc. $0.03 +0.00% -2.23 $1.53M 0.00%

About FSD Pharma Inc.

FSD Pharma Inc. is a biopharmaceutical research and development company, operating through its various subsidiaries. The firm's leading drug candidate, FSD-201, is currently undergoing Phase II clinical trials for the treatment of COVID-19 disease. Additionally, FSD Pharma is actively developing Lucid-PSYCH, a psychoactive molecule identified for its potential in addressing neuropsychiatric conditions such as depressive disorder. They are also advancing Lucid-MS, a proprietary new chemical entity which, in preclinical models, has demonstrated the capacity to prevent and reverse myelin degradation—the fundamental mechanism behind multiple sclerosis. Established in 1998, FSD Pharma Inc. is headquartered in Toronto, Canada.

FSD Pharma Inc. is headquartered in CA.

FSD Pharma Inc. (HUGE) stock trades at $0.09 with a market capitalization of $66671. The stock is valued at a price-to-earnings (P/E) ratio of -0.19, price-to-book of 0.27, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.09 and $109.19, and currently trades 99.9% below its 52-week high.

On profitability, FSD Pharma Inc. generates a return on equity (ROE) of -84.81%, return on capital employed of -154.10%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.fsdpharma.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides